Medicus Pharma Ltd. Deal History & Licensing Activity
Medicus Pharma Ltd. is a biotech. Over the past three years, Medicus Pharma Ltd. has been involved in 2 licensing and acquisition transactions, with a primary focus on ADC (2 deals).
Deals (12mo)
2
Active Trials
0
Top Modality
ADC
Focus Area
Oncology
Medicus Pharma Ltd. Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Medicus Pharma Ltd. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| PF-08046031 (CD228V) | Pfizer Inc. | ADC | Phase 1 | license | Sep 2, 2026 |
| Teverelix | LifeArc | Peptides | Phase 2 | license | Jan 22, 2026 |
Medicus Pharma Ltd. Pipeline Focus
Therapeutic areas and modalities where Medicus Pharma Ltd. is most active based on deal history and clinical trial data.
See How Your Asset Matches Medicus Pharma Ltd.'s Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Oncology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Oncology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for oncology
ADC Benchmarks
Upfront, milestone, and royalty benchmarks for adc deals
Peptides Benchmarks
Upfront, milestone, and royalty benchmarks for peptides deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 700+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Medicus Pharma Ltd. Licensing & Deal Activity
Medicus Pharma Ltd. is a biotech company that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Medicus Pharma Ltd. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Medicus Pharma Ltd. include Oncology (4 deals and trials). In terms of modality, Medicus Pharma Ltd. has shown particular interest in adc, peptides.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Medicus Pharma Ltd. and 700+ other biopharma companies. Use our Solidus to benchmark your asset against Medicus Pharma Ltd.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.